IsoPlexis Corp

Operating margin

−604.0%

Net margin

−632.4%

Return on equity

−256.9%

Return on assets

−97.2%

Return on capital (ROCE)

−110.8%

Liabilities / assets

62.2%

Debt / equity

1.64×

Book value / share

$1.06

Revenue growth (YoY)

−2.9%

Net income growth (YoY)

—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Altman Z″ (distress)

-9.51distress

Accruals / assets

−8.6%clean

Piotroski F-Score

2/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

• Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsMar 22, 2023
• Shareholder voteMar 16, 2023
• Other material eventMar 9, 2023
• Entered a material agreementFeb 16, 2023
• Results of operationsJan 12, 2023
• Entered a material agreement · Other material eventDec 21, 2022
• Results of operationsNov 10, 2022
• Regulation FD disclosureSep 12, 2022

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.